A leading stop-loss carrier partnered with IQVIA to better evaluate high-cost, high-need populations and improve pricing strategies amid rising costs and new therapies. IQVIA delivered customized data extracts on patient cohorts with high claims, integrated through Snowflake, and supported by healthcare subject matter expertise. This enabled improved accuracy in population risk assessment, product design, and quoting decisions. The result: enhanced predictive power, confidence in expansion opportunities, and adoption of data-driven strategies to remain competitive.

Join for free to read